ATE497500T1 - Kristalline base von escitalopram und orodispergierbare tabletten, die escitaloprambase enthalten - Google Patents

Kristalline base von escitalopram und orodispergierbare tabletten, die escitaloprambase enthalten

Info

Publication number: ATE497500T1
Authority: AT; Austria
Prior art keywords: escitalopram; base; tablets containing; orodispersible tablets; crystalline
Prior art date: 2005-06-22

Application number

AT06742481T

Other languages

English (en)

Inventor

Robert Dancer

Hans Petersen

Ole Nielsen

Michael Rock

Helle Eliasen

Ken Liljegren

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-22

Filing date

2006-06-22

Publication date

2011-02-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37546630&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE497500(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-06-22 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2011-02-15 Application granted granted Critical

2011-02-15 Publication of ATE497500T1 publication Critical patent/ATE497500T1/de

Links

WSEQXVZVJXJVFP-FQEVSTJZSA-N escitalopram Chemical compound C1([C@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-FQEVSTJZSA-N 0.000 title 2
229960004341 escitalopram Drugs 0.000 title 2

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B63/00—Purification; Separation; Stabilisation; Use of additives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Furan Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AT06742481T 2005-06-22 2006-06-22 Kristalline base von escitalopram und orodispergierbare tabletten, die escitaloprambase enthalten ATE497500T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200500912		2005-06-22
PCT/DK2006/000366 WO2006136169A2 (en)	2005-06-22	2006-06-22	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base

Publications (1)

Publication Number	Publication Date
ATE497500T1 true ATE497500T1 (de)	2011-02-15

Family

ID=37546630

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AT06742481T ATE497500T1 (de)	2005-06-22	2006-06-22	Kristalline base von escitalopram und orodispergierbare tabletten, die escitaloprambase enthalten
AT0900506U AT10983U1 (de)	2005-06-22	2006-06-22	Kristalline base von escitalopram und orodispersible tabletten, die escitalopram-base umfassen
AT0041709U AT11883U1 (de)	2005-06-22	2009-07-07	Kristalline base von escitalopram und orodispersible tabletten, die escitalopram-base umfassen

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
AT0900506U AT10983U1 (de)	2005-06-22	2006-06-22	Kristalline base von escitalopram und orodispersible tabletten, die escitalopram-base umfassen
AT0041709U AT11883U1 (de)	2005-06-22	2009-07-07	Kristalline base von escitalopram und orodispersible tabletten, die escitalopram-base umfassen

Country Status (39)

Country	Link
EP (3)	EP2325177A1 (de)
JP (5)	JP4906852B2 (de)
KR (5)	KR101340815B1 (de)
CN (2)	CN101928269A (de)
AR (2)	AR055062A1 (de)
AT (3)	ATE497500T1 (de)
AU (2)	AU2006261452B2 (de)
BG (1)	BG66086B1 (de)
BR (1)	BRPI0612295A2 (de)
CA (2)	CA2646780A1 (de)
CY (1)	CY1112392T1 (de)
CZ (3)	CZ300686B6 (de)
DE (2)	DE112006001619T5 (de)
DK (3)	DK1896439T4 (de)
EA (2)	EA201001108A1 (de)
EE (1)	EE00773U1 (de)
ES (2)	ES2356838T5 (de)
FI (2)	FI20077133L (de)
GB (2)	GB2442160B (de)
HR (1)	HRP20110093T4 (de)
HU (1)	HUP0800135A3 (de)
IL (1)	IL187454A0 (de)
IS (1)	IS8705A (de)
LT (1)	LT5550B (de)
LV (1)	LV13677B (de)
MX (1)	MX2007015328A (de)
MY (2)	MY143252A (de)
NO (2)	NO20080359L (de)
PL (2)	PL1896439T5 (de)
PT (1)	PT1896439E (de)
RS (1)	RS51575B2 (de)
SG (1)	SG169358A1 (de)
SI (1)	SI1896439T2 (de)
SK (1)	SK500402007A3 (de)
TR (2)	TR200708792T1 (de)
TW (2)	TWI358407B (de)
UA (1)	UA86536C2 (de)
WO (1)	WO2006136169A2 (de)
ZA (2)	ZA200711066B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0123400D0 (en)	2001-09-28	2001-11-21	Novartis Ag	Organic compounds
WO2008059514A2 (en) *	2006-07-31	2008-05-22	Cadila Healthcare Limited	Process for preparing escitalopram
EP2134325A2 (de) *	2007-03-01	2009-12-23	Aurobindo Pharma Limited	Stabile solide dosierformen eines antidepressivums
HUE028897T2 (en)	2010-07-23	2017-01-30	H Lundbeck As	A method of purifying pharmaceutically acceptable salts of escitalopram
CN103360353A (zh) *	2013-08-07	2013-10-23	中国药科大学	草酸艾司西酞普兰杂质的制备方法
JP2018016569A (ja) *	2016-07-26	2018-02-01	株式会社トクヤマ	（１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法
JP6423133B1 (ja) *	2017-04-10	2018-11-14	東和薬品株式会社	エスシタロプラム医薬組成物
CN110711198B (zh) *	2018-07-12	2022-03-15	山东大学	D-甘露糖在制备抗抑郁药物中的应用
KR102331187B1 (ko)	2019-04-09	2021-11-26	주식회사 라이트팜텍	에스시탈로프람을 함유하는 안정성이 우수한 경구용 액제 조성물 및 그의 제조방법
EP4277661A1 (de) *	2021-01-18	2023-11-22	Anton Frenkel	Pharmazeutische darreichungsform

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1526331A (en)	1976-01-14	1978-09-27	Kefalas As	Phthalanes
GB8814057D0 (en)	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
JPH05222041A (ja) *	1992-02-13	1993-08-31	Mitsubishi Gas Chem Co Inc	アデニン誘導体の精製法
EP0743850B1 (de) *	1994-01-27	1999-10-06	The Board Of Regents Of The University Of Oklahoma	Schnell auflösende orale darreichungsform
US5607697A (en) *	1995-06-07	1997-03-04	Cima Labs, Incorporated	Taste masking microparticles for oral dosage forms
EP0993524B1 (de)	1997-06-30	2002-11-20	Beloit Technologies, Inc.	Verfahren und vorrichtung zum auftragen einer beschichtung auf eine bei hoher geschwindigkeit laufende papierbahn
SK283309B6 (sk)	1997-07-08	2003-05-02	H. Lundbeck A/S	Spôsob výroby citalopramu a medziprodukty
DK1042310T3 (da)	1997-11-11	2002-12-02	Lundbeck & Co As H	Fremgangsmåde til fremstilling af citalopram
FR2785538B1 (fr) *	1998-11-06	2004-04-09	Prographarm Laboratoires	Comprime a delitement rapide perfectionne
US20020071864A1 (en) *	1999-03-25	2002-06-13	Yuhan Corporation	Rapidly disintegrable tablet for oral administration
ITMI991579A1 (it)	1999-06-25	2001-01-15	Lundbeck & Co As H	Metodo per la preparazione di citalopram
ITMI991581A1 (it)	1999-06-25	2001-01-15	Lundbeck & Co As H	Metodo per la preparazione di citalopram
JP2001226372A (ja) *	1999-12-06	2001-08-21	Sumika Fine Chemicals Co Ltd	ロサルタンの結晶性または結晶化された酸付加塩およびロサルタンの精製方法
GB2357762B (en) *	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
AU2001294192A1 (en) *	2000-10-06	2002-04-22	Takeda Chemical Industries Ltd.	Solid preparations
WO2002032403A1 (fr) *	2000-10-16	2002-04-25	Daiichi Pharmaceutical Co., Ltd.	Compositions medicales pouvant se desintegrer rapidement dans la cavite buccale et leur procede de production
US7799342B2 (en) *	2000-12-06	2010-09-21	Wyeth Llc	Fast dissolving tablet
CA2360303C (en) *	2000-12-22	2003-08-12	Marco Villa	Process for the preparation of pure citalopram
SK284418B6 (sk) *	2000-12-28	2005-04-01	H. Lundbeck A/S	Spôsob výroby citalopramu
CZ20033267A3 (en) *	2001-05-01	2004-06-16	H. Lundbeck A/S	The use of enantiomeric pure escitalopram
US6872405B2 (en) *	2001-05-10	2005-03-29	Yamanouchi Pharmaceutical Co., Ltd.	Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
GB0113842D0 (en) *	2001-06-07	2001-08-01	Boots Co Plc	Therapeutic agents
AR034612A1 (es) *	2001-06-25	2004-03-03	Lundbeck & Co As H	Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR034759A1 (es)	2001-07-13	2004-03-17	Lundbeck & Co As H	Metodo para la preparacion de escitalopram
PT1522539E (pt) *	2001-07-31	2007-03-30	Lundbeck & Co As H	Composição cristalina contendo escitalopram
IS7239A (is) *	2001-12-14	2004-04-29	H. Lundbeck A/S	Aðferð til framleiðslu á essítalóprami
AU2003222435A1 (en) *	2002-01-07	2003-07-24	Sun Pharmaceutical Industries Limited	Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
FR2834889B1 (fr) *	2002-01-18	2004-04-02	Roquette Freres	Forme pharmaceutique solide orodispersible
GB0204607D0 (en) *	2002-02-27	2002-04-10	Matrix Lab Ltd	Process
WO2003092659A1 (en) *	2002-05-03	2003-11-13	Skyepharma Canada Inc.	Oral dosage forms comprising fenofibrate
MEP5808A (xx)	2002-12-23	2010-02-10	Lundbeck & Co As H	Ecitalopram bromhidrat i postupak za njegovo pripremanje
CN1510024A (zh) *	2002-12-24	2004-07-07	北京德众万全药物技术开发有限公司	可用于制备西酞普兰(s)-对映异构体的新的化合物及其制备方法
DE10305984A1 (de) *	2003-02-13	2004-09-02	Helm Ag	Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
AU2004238321B2 (en) *	2003-05-07	2009-08-27	Samyang Biopharmaceuticals Corporation	Highly plastic granules for making fast melting tablets
ES2688193T3 (es) *	2003-10-15	2018-10-31	Fuji Chemical Industry Co., Ltd.	Comprimido de disgregación rápida en la cavidad oral
WO2005049596A1 (en) *	2003-11-20	2005-06-02	Natco Pharma Limited	A process for the preparation of high purity escitalopram
HU227491B1 (en) *	2003-11-25	2011-07-28	Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag	Tablet containing citalopram hydrogen bromide
NZ549100A (en) *	2004-03-05	2010-02-26	Lundbeck & Co As H	Crystalline composition containing escitalopram oxalate
EP1877394A1 (de) *	2005-04-04	2008-01-16	Jubilant Organosys Limited	Verfahren zur herstellung von escitalopram oder seinen säureadditionssalzen

2006
- 2006-06-15 TW TW100102601A patent/TWI358407B/zh not_active IP Right Cessation
- 2006-06-15 TW TW095121358A patent/TWI347942B/zh not_active IP Right Cessation
- 2006-06-21 MY MYPI20062933A patent/MY143252A/en unknown
- 2006-06-21 MY MYPI2010000618A patent/MY143239A/en unknown
- 2006-06-21 AR ARP060102654A patent/AR055062A1/es not_active Application Discontinuation
- 2006-06-22 PL PL06742481T patent/PL1896439T5/pl unknown
- 2006-06-22 MX MX2007015328A patent/MX2007015328A/es active IP Right Grant
- 2006-06-22 EA EA201001108A patent/EA201001108A1/ru unknown
- 2006-06-22 PT PT06742481T patent/PT1896439E/pt unknown
- 2006-06-22 GB GB0724557A patent/GB2442160B/en not_active Expired - Fee Related
- 2006-06-22 PL PL384185A patent/PL384185A1/pl unknown
- 2006-06-22 EP EP10179395A patent/EP2325177A1/de not_active Withdrawn
- 2006-06-22 EA EA200800102A patent/EA019239B1/ru not_active IP Right Cessation
- 2006-06-22 AU AU2006261452A patent/AU2006261452B2/en not_active Withdrawn - After Issue
- 2006-06-22 RS RS20110057A patent/RS51575B2/sr unknown
- 2006-06-22 CA CA002646780A patent/CA2646780A1/en not_active Abandoned
- 2006-06-22 FI FI20077133A patent/FI20077133L/fi unknown
- 2006-06-22 AT AT06742481T patent/ATE497500T1/de active
- 2006-06-22 ES ES06742481.2T patent/ES2356838T5/es active Active
- 2006-06-22 SK SK50040-2007A patent/SK500402007A3/sk unknown
- 2006-06-22 CA CA2612827A patent/CA2612827C/en not_active Expired - Fee Related
- 2006-06-22 SG SG201100648-3A patent/SG169358A1/en unknown
- 2006-06-22 KR KR1020117005777A patent/KR101340815B1/ko active Active
- 2006-06-22 WO PCT/DK2006/000366 patent/WO2006136169A2/en not_active Ceased
- 2006-06-22 CZ CZ20080430A patent/CZ300686B6/cs not_active IP Right Cessation
- 2006-06-22 DK DK06742481.2T patent/DK1896439T4/en active
- 2006-06-22 CZ CZ20070898A patent/CZ299906B6/cs not_active IP Right Cessation
- 2006-06-22 DE DE112006001619T patent/DE112006001619T5/de not_active Withdrawn
- 2006-06-22 CN CN201010286088XA patent/CN101928269A/zh active Pending
- 2006-06-22 DE DE602006019961T patent/DE602006019961D1/de active Active
- 2006-06-22 KR KR1020117015711A patent/KR20110084341A/ko not_active Ceased
- 2006-06-22 EP EP06742481.2A patent/EP1896439B2/de active Active
- 2006-06-22 EP EP10179318A patent/EP2385044A1/de not_active Withdrawn
- 2006-06-22 CN CNA2006800200393A patent/CN101189220A/zh active Pending
- 2006-06-22 HU HU0800135A patent/HUP0800135A3/hu unknown
- 2006-06-22 AT AT0900506U patent/AT10983U1/de not_active IP Right Cessation
- 2006-06-22 KR KR1020077028918A patent/KR20080018191A/ko not_active Ceased
- 2006-06-22 KR KR1020107026804A patent/KR20100133023A/ko not_active Ceased
- 2006-06-22 CZ CZ20080429A patent/CZ301286B6/cs not_active IP Right Cessation
- 2006-06-22 TR TR2007/08792T patent/TR200708792T1/xx unknown
- 2006-06-22 GB GB0811164A patent/GB2448834B/en not_active Expired - Fee Related
- 2006-06-22 JP JP2008517323A patent/JP4906852B2/ja active Active
- 2006-06-22 HR HRP20110093TT patent/HRP20110093T4/hr unknown
- 2006-06-22 ES ES200750085A patent/ES2319073B1/es not_active Expired - Fee Related
- 2006-06-22 ZA ZA200711066A patent/ZA200711066B/xx unknown
- 2006-06-22 TR TR2010/00625T patent/TR201000625T1/xx unknown
- 2006-06-22 SI SI200630923T patent/SI1896439T2/sl unknown
- 2006-06-22 FI FI20080548A patent/FI20080548L/fi unknown
- 2006-06-22 KR KR1020127014205A patent/KR20120064140A/ko not_active Ceased
- 2006-06-22 EE EEU200800003U patent/EE00773U1/xx not_active IP Right Cessation
- 2006-06-22 BR BRPI0612295-7A patent/BRPI0612295A2/pt not_active IP Right Cessation
- 2006-06-22 UA UAA200800362A patent/UA86536C2/ru unknown
2007
- 2007-11-18 IL IL187454A patent/IL187454A0/en unknown
- 2007-12-19 BG BG10110024A patent/BG66086B1/bg unknown
- 2007-12-21 LV LVP-07-157A patent/LV13677B/lv unknown
2008
- 2008-01-14 IS IS8705A patent/IS8705A/is unknown
- 2008-01-18 NO NO20080359A patent/NO20080359L/no unknown
- 2008-01-21 DK DK200800075A patent/DK200800075A/da not_active Application Discontinuation
- 2008-01-21 LT LT2008005A patent/LT5550B/lt not_active IP Right Cessation
- 2008-10-07 JP JP2008260742A patent/JP4415056B2/ja active Active
2009
- 2009-02-27 DK DKPA200900284A patent/DK200900284A/da not_active Application Discontinuation
- 2009-03-10 ZA ZA200901698A patent/ZA200901698B/en unknown
- 2009-05-12 JP JP2009115279A patent/JP2009179634A/ja active Pending
- 2009-05-12 JP JP2009115280A patent/JP2009179635A/ja active Pending
- 2009-07-07 AT AT0041709U patent/AT11883U1/de not_active IP Right Cessation
2010
- 2010-03-05 AU AU2010200844A patent/AU2010200844A1/en not_active Withdrawn
- 2010-12-20 NO NO20101777A patent/NO20101777L/no not_active Application Discontinuation
- 2010-12-27 AR ARP100104958A patent/AR079750A2/es not_active Application Discontinuation
2011
- 2011-02-03 CY CY20111100116T patent/CY1112392T1/el unknown
- 2011-11-24 JP JP2011255804A patent/JP5731957B2/ja active Active

Also Published As

Publication number	Publication date
FI20080548A7 (fi)	2008-10-07
JP5731957B2 (ja)	2015-06-10
ES2356838T3 (es)	2011-04-13
SK500402007A3 (sk)	2008-05-06
JP4906852B2 (ja)	2012-03-28
GB0724557D0 (en)	2008-01-23
DK1896439T3 (da)	2011-02-28
GB2442160B (en)	2010-01-20
MY143252A (en)	2011-04-15
JP2008546724A (ja)	2008-12-25
KR20100133023A (ko)	2010-12-20
JP2009046506A (ja)	2009-03-05
DE602006019961D1 (de)	2011-03-17
ES2319073B1 (es)	2010-02-26
HUP0800135A2 (en)	2008-06-30
CZ299906B6 (cs)	2008-12-29
ZA200901698B (en)	2010-04-28
TW200740785A (en)	2007-11-01
LV13677B (en)	2008-05-20
ZA200711066B (en)	2009-07-29
UA86536C2 (ru)	2009-04-27
AU2006261452A1 (en)	2006-12-28
SG169358A1 (en)	2011-03-30
AU2006261452B2 (en)	2010-02-04
HRP20110093T1 (hr)	2011-03-31
EE00773U1 (et)	2008-10-15
CA2646780A1 (en)	2006-12-28
TR200708792T1 (tr)	2008-05-21
BG110024A (bg)	2008-05-30
KR20110084341A (ko)	2011-07-21
FI20080548L (fi)	2008-10-07
EA019239B1 (ru)	2014-02-28
ES2356838T5 (es)	2015-01-26
DK200800075A (da)	2008-03-15
WO2006136169A2 (en)	2006-12-28
AT11883U1 (de)	2011-06-15
IL187454A0 (en)	2008-02-09
KR101340815B1 (ko)	2013-12-11
TW201130808A (en)	2011-09-16
LT2008005A (en)	2008-10-27
ES2319073A1 (es)	2009-05-01
GB2442160A (en)	2008-03-26
RS51575B (sr)	2011-08-31
PT1896439E (pt)	2011-02-15
LT5550B (lt)	2009-03-25
EP2385044A1 (de)	2011-11-09
EP2325177A1 (de)	2011-05-25
RS51575B2 (sr)	2018-02-28
CN101189220A (zh)	2008-05-28
CA2612827A1 (en)	2006-12-28
AU2010200844A1 (en)	2010-04-01
CY1112392T1 (el)	2015-12-09
AT10983U1 (de)	2010-02-15
AR055062A1 (es)	2007-08-01
NO20101777L (no)	2008-01-18
GB2448834B (en)	2010-01-20
CA2612827C (en)	2010-11-30
KR20120064140A (ko)	2012-06-18
EP1896439A2 (de)	2008-03-12
DK200900284A (da)	2009-02-27
EP1896439B1 (de)	2011-02-02
PL384185A1 (pl)	2008-06-23
SI1896439T1 (sl)	2011-03-31
NO20080359L (no)	2008-01-18
MY143239A (en)	2011-04-15
TWI347942B (en)	2011-09-01
GB0811164D0 (en)	2008-07-23
TWI358407B (en)	2012-02-21
DK1896439T4 (en)	2015-01-12
HUP0800135A3 (en)	2009-01-28
EP1896439B2 (de)	2014-10-15
PL1896439T5 (pl)	2016-01-29
CZ2007898A3 (cs)	2008-01-23
AR079750A2 (es)	2012-02-15
WO2006136169A3 (en)	2007-10-18
JP2009179634A (ja)	2009-08-13
IS8705A (is)	2008-01-14
GB2448834A (en)	2008-10-29
JP2009179635A (ja)	2009-08-13
DE112006001619T5 (de)	2008-06-12
CZ300686B6 (cs)	2009-07-15
JP2012072168A (ja)	2012-04-12
FI20077133A7 (fi)	2007-12-20
EA200800102A1 (ru)	2008-04-28
BRPI0612295A2 (pt)	2011-01-04
PL1896439T3 (pl)	2011-04-29
BG66086B1 (bg)	2011-03-31
SI1896439T2 (sl)	2014-12-31
MX2007015328A (es)	2008-02-15
KR20110033310A (ko)	2011-03-30
TR201000625T1 (tr)	2010-03-22
CZ301286B6 (cs)	2009-12-30
CN101928269A (zh)	2010-12-29
JP4415056B2 (ja)	2010-02-17
FI20077133L (fi)	2007-12-20
EA201001108A1 (ru)	2011-02-28
HRP20110093T4 (hr)	2015-02-27
KR20080018191A (ko)	2008-02-27

Legal Events

Date

Code

Title

Description

2011-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1896439

Country of ref document: EP

Publication	Publication Date	Title
DE602005004988D1 (de)	2008-04-10	Reversibele thermochromische Zusammensetzung und Mikrokapseln, die diese enthalten
DE10397017A5 (de)	2015-05-28	Biosensor, Biosensorchip und Biosensoreinrichtung
DE60325567D1 (de)	2009-02-12	Matrix für die modifizierte freigabe von aktiven substanzen
LU92426I2 (fr)	2014-06-10	Canagliflozine
NO20045679D0 (no)	2004-12-28	Nye fysiologisk aktive substanser
DE60325255D1 (de)	2009-01-22	Duftzusammensetzung
HUS1500006I1 (hu)	2015-02-18	Benzotiazol-származék vegyületek, kompozíciók és alkalmazások
ME01394B (de)	2013-12-20	Kristallinform gamma-d von Ivabradine-hydrochlorid, Verfahren zu dessen Herstellung und diesen enthaltende Pharmazeutische Zusammensetzung
SK4326U (sk)	2005-12-01	Farmaceutická kompozícia s predĺženým uvoľňovaním
PT1467724E (pt)	2006-08-31	Composicao farmaceutica orodispersavel de agomelatina
IL187454A0 (en)	2008-02-09	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP1548121A4 (de)	2010-11-03	Neue physiologisch aktive substanzen
EP1695761A4 (de)	2012-04-04	Katalysatorzusammensetzung
EP1886678A4 (de)	2009-06-10	Stabile tablette mit droxidopa
ATE405943T1 (de)	2008-09-15	Quecksilberfreisetzende zusammensetzungen und herstellungsverfahren dafür
DE602004023623D1 (de)	2009-11-26	Chirale verbindungen und zusammensetzungen, die diese enthalten
DE60334012D1 (de)	2010-10-14	Valerolactonverbindungen und parf mzusammensetzung
ATE524186T1 (de)	2011-09-15	Pharmazeutische kombinationen bestehend aus meloxicam, tramadol und paracetamol
IL190464A0 (en)	2008-11-03	Cyclic n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
DE602004009733D1 (de)	2007-12-13	Dynamisches Ratenteilungsverfahren
EP1687398A4 (de)	2008-09-10	Hiv-abhängige expressionskonstrukte und verwendungen dafür
EP1687022A4 (de)	2008-02-13	Renta: hiv-immunogen und seine anwendungen
DE60308862D1 (de)	2006-11-16	Verbindungen und zusammensetzungen zur behandlung von diabetes und erkrankungen, die mit diabetes in zusammenhang stehen
DE60302922D1 (de)	2006-02-02	Hydrierung von prochiralen Ketonen
ES1052229Y (es)	2003-03-16	Base de andamio.